Try it
PSM · Communicable diseases: triple drug therapy for lymphatic filariasis
Sample itemIn districts using triple-drug therapy for lymphatic filariasis, which three drugs are given together as a single annual dose?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
D. DEC, albendazole and ivermectin
The triple-drug regimen adds ivermectin to the standard annual diethylcarbamazine and albendazole combination used in mass drug administration. It clears microfilaraemia faster. Praziquantel is for schistosomiasis and doxycycline is used for morbidity management.
Option by option
A. DEC, albendazole and doxycycline
Doxycycline targets Wolbachia and is not part of the MDA combination.
B. DEC, ivermectin and praziquantel
Praziquantel has no activity against filarial worms.
C. Albendazole, ivermectin and mebendazole
Mebendazole duplicates albendazole and there is no DEC to clear microfilariae.
D. DEC, albendazole and ivermectin (correct)
Correct. Ivermectin is added to DEC and albendazole.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More PSM questions
- BiostatisticsOf 200 people who truly have a disease, a screening test is positive in 180. What is the…
- Environmental healthAfter one hour of contact time, what residual free chlorine level is generally recommend…
- EpidemiologyWhich study design is the most efficient for investigating risk factors of a rare disease?
- BiostatisticsIn hypothesis testing, a Type I error is: